NEU 3.50% $14.05 neuren pharmaceuticals limited

Takeover discussion, page-16

  1. 2,211 Posts.
    lightbulb Created with Sketch. 326
    I would like to see Jon pushing for deals for ROW now, any deal that may arise prior to Acadia lodging Trof for FDA approval, would ensure NEU is valued much higher than $4 snd make it harder for ACADIA to buy us cheap. I have no doubt we will already be in some discussions for ROW.
    Company is now derisked after PH3 success
    Last edited by zedcorp: 15/12/21
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.